Takeda Okays Phase 3 Trial of ALUNBRIG
By Dipo Olowookere Takeda Pharmaceutical Company Limited has disclosed that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer ...
By Dipo Olowookere Takeda Pharmaceutical Company Limited has disclosed that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer ...
By Modupe Gbadeyanka Takeda Pharmaceutical Company Limited today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 ...
By Dipo Olowookere Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals Inc. today announced that they have entered into a definitive ...
By Modupe Gbadeyanka Japanese firm, Takeda Pharmaceutical Company Limited, has announced that the Biomedical Advanced Research and Development Authority (BARDA) ...
© 2024 Businesspost - Businesspost
© 2024 Businesspost - Businesspost